Duchenne Care UK podcast series launched

On World Duchenne Awareness Day 2026, we are pleased to share the launch of the Duchenne Care UK podcast series, supporting the goal of delivering consistent, high-quality care across the UK. The series is based on the Duchenne Care UK Patient and Family Guides, and...

Duchenne Care UK orthopaedic guideline recognised by NICE

We are pleased to share that NICE has recognised another clinical guideline published as part of the Duchenne Care UK national programme that we fund. NICE (the National Institute for Health and Care Excellence) has reviewed Duchenne Care UK’s recommendations on...
Duchenne Care UK launches psychosocial guidelines

Duchenne Care UK launches psychosocial guidelines

We are delighted to share that psychosocial guidelines for Duchenne muscular dystrophy have been published by Duchenne Care UK. We are proud to be a key funder of the psychosocial programme, which is part of a wider, multi‑year national effort by Duchenne Care UK to...

Solid announces positive clinical update

Solid Biosciences has announced a positive clinical update on the SGT-003 gene therapy programme. This update includes interim safety and biomarker data from the ongoing Phase 1/2 Inspire Duchenne clinical trial. To date, 40 participants have been dosed with SGT-003...

DMD Care UK respiratory guideline recognised by NICE

The Duchenne Research Fund is delighted to share that NICE has recognised the respiratory care guidelines that were created and published by the DMD Care UK programme that we fund. This follows NICE’s recognition of DMD Care UK’s cardiac guidelines in...

DMD Care UK cardiac guideline recognised by NICE

On World Duchenne Awareness Day 2025, the Duchenne Research Fund is delighted to share that NICE has recognised the cardiac care guidelines that were created and published by the DMD Care UK programme that we fund. As stated on NICE’s website: “We think...

DMD Care UK publishes annual meeting report

DMD Care UK has published a report following its national meeting earlier this year, sharing insights into the success of its workshops and knowledge sharing. More than 80 clinical professionals attended in person, and there were more than 170 dial-ins to online...

Duchenne community campaigns for givinostat

The UK’s National Institute for Health and Care Excellence (NICE) has announced it will seek further guidance on whether new treatment givinostat should be made routinely available on the NHS. NICE held its initial committee meeting to appraise the drug in July,...
DMD Care UK national meeting drives improved care

DMD Care UK national meeting drives improved care

Pictured: DRF director of operations Sheli Rodney (second from right) with fellow members of the Psychosocial Working Group: disability and education specialist Dr Janet Hoskin, DMD Care UK manager Cathy Turner, Pathfinders Neuromuscular Alliance trustee Benjamin...

NICE approves DRF-funded treatment for Duchenne

New medicine for Duchenne muscular dystrophy, funded by Duchenne Research Fund and patient groups, becomes first approved treatment in the UK for all patients with Duchenne The National Institute for Health and Care Excellence (NICE) has approved vamorolone for use on...